The stock price of CRISPR Therapeutics AG (NASDAQ: CRSP) has surged by 1.69 when compared to previous closing price of 46.7, but the company has
CRISPR Therapeutics AG (NASDAQ: CRSP) has seen a rise in its stock price by 2453800 in relation to its previous close of 45.55. However, the
The 36-month beta value for CRSP is also noteworthy at 1.75. There are mixed opinions on the stock, with 12 analysts rating it as a
The stock of CRISPR Therapeutics AG (CRSP) has gone up by 13.91% for the week, with a 16.46% rise in the past month and a
Additionally, the 36-month beta value for CRSP is 1.74. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5
The 36-month beta value for CRSP is also noteworthy at 1.76. There are mixed opinions on the stock, with 12 analysts rating it as a
© 2024, Powered by Smart TechOne